KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · Real-Time Price · USD

16.54

+0.63 (3.96%)

At close: Jan 22, 2026, 4:00 PM EST

16.54

0.00 (0.00%)

After-hours: Jan 22, 2026, 4:38 PM EST

KalVista Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jan '26 Jan 22, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2016 - 2020
Market Capitalization	836	685	479	291	312	607	Upgrade
Market Cap Growth	87.37%	42.97%	64.29%	-6.71%	-48.53%	211.76%	Upgrade
Enterprise Value	783	538	411	128	126	558	Upgrade
Last Close Price	16.54	13.77	11.35	8.53	12.73	24.97	Upgrade
PS Ratio	586.28	-	-	-	-	-	Upgrade
PB Ratio	20.41	7.18	2.32	1.81	1.69	2.36	Upgrade
P/TBV Ratio	20.50	7.18	2.32	1.81	1.69	2.36	Upgrade
EV/Sales Ratio	549.11	-	-	-	-	-	Upgrade
Debt / Equity Ratio	3.40	1.18	0.04	0.05	0.04	0.02	Upgrade
Asset Turnover	0.01	-	-	-	-	-	Upgrade
Quick Ratio	5.16	5.22	9.70	11.18	15.81	26.67	Upgrade
Current Ratio	5.37	5.35	9.90	11.46	16.73	27.04	Upgrade
Return on Equity (ROE)	-190.18%	-121.50%	-68.90%	-53.69%	-37.23%	-27.13%	Upgrade
Return on Assets (ROA)	-60.98%	-48.34%	-41.94%	-35.80%	-25.38%	-19.86%	Upgrade
Return on Capital Employed (ROCE)	-114.50%	-91.40%	-66.10%	-65.90%	-50.20%	-22.10%	Upgrade
Earnings Yield	-24.29%	-26.80%	-26.45%	-31.88%	-26.35%	-7.62%	Upgrade
FCF Yield	-20.08%	-22.40%	-18.64%	-26.23%	-25.31%	-4.98%	Upgrade
Buyback Yield / Dilution	-29.51%	-34.98%	-31.89%	-13.96%	-28.17%	-7.58%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q